Recursion Pharmaceuticals: Q4 Earnings Snapshot

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Monday reported a loss of $57.5 million in its fourth quarter.

The Salt Lake City-based company said it had a loss of 31 cents per share.

The biotechnology company posted revenue of $13.7 million in the period.

For the year, the company reported a loss of $239.5 million, or $1.36 per share. Revenue was reported as $39.8 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on RXRX at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up